Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Fondation Imagine manages a patent portfolio in the Biotechnology & Pharmaceuticals technology area. The portfolio currently has 2 pending office actions. This activity is distributed across distinct examiners and 2 distinct art units. This distribution suggests that the company is pursuing multiple lines of research or application within the biotechnology sector, requiring a nuanced management approach.
GARY W COUNTS is identified as the busiest examiner for this entity, currently overseeing 1 pending office action. Practitioners should note that with multiple examiners involved, there is a range of perspectives to consider. This diversity provides data points on how the USPTO views the company's technologies across different examination silos.
The involvement of 2 distinct art units suggests that the company's technology spans different examination categories. This diversity requires a prosecution strategy that can adapt to different standards and technical expectations. The 2 pending office actions represent the current workload that must be managed across these different technical and personnel environments. Effectively navigating the distinct art units is critical for maintaining the overall health of the patent portfolio.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| COUNTS, GARY W | 1 | 58.9% | +29.5% |
| SULLIVAN, STEPHANIE LAUREN | 1 | 58.1% | +40.9% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17274966 | METHODS FOR INCREASING FETAL HEMOGLOBIN CONTENT IN EUKARYOTIC CELLS AND USES THEREOF FOR THE TREATMENT OF HEMOGLOBINOPATHIES | SULLIVAN, STEPHANIE LAUREN | 12d |
| 18017249 | Type 1 IFN Assays and Methods of Diagnosis for Susceptibility to and Treatment of Viral Disease and Viral Vaccines, Including Covid -19 | COUNTS, GARY W | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17274966 | METHODS FOR INCREASING FETAL HEMOGLOBIN CONTENT IN EUKARYOTIC CELLS AND USES THEREOF FOR THE TREATMENT OF HEMOGLOBINOPATHIES | SULLIVAN, STEPHANIE LAUREN | 12d |
| 18017249 | Type 1 IFN Assays and Methods of Diagnosis for Susceptibility to and Treatment of Viral Disease and Viral Vaccines, Including Covid -19 | COUNTS, GARY W | — |
| Art Unit | Apps |
|---|---|
| 1678 | 1 |
| 1635 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18017249 | Type 1 IFN Assays and Methods of Diagnosis for Susceptibility to and Treatment of Viral Disease and Viral Vaccines, Including Covid -19 | COUNTS, GARY W | 1678 | §101§103§112 | Non-Final OA | — | Pending | Jan 20, 2023 |
| 17274966 | METHODS FOR INCREASING FETAL HEMOGLOBIN CONTENT IN EUKARYOTIC CELLS AND USES THEREOF FOR THE TREATMENT OF HEMOGLOBINOPATHIES | SULLIVAN, STEPHANIE LAUREN | 1635 | §103§112 | Non-Final OA | 12d | Pending | Mar 10, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial